Hidradenitis Suppurativa and IL-17 Inhibitors: A Focus on Trials and Real-Life Data.

Bimzelx (bimekizumab-bkzx) - UCB

Cosentyx (secukinumab) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42195203

Claudio Brescia; Fabrizio Martora; Matteo Megna; Nello Tommasino; Valeria Esposito

May 28, 2026